-
Forward Look
New Guidelines for Radiation Therapy in Pancreatic CancerRecommendations address conflicts and research gaps.
by Ashley P. Taylor
-
Trials InterruptedCOVID-19 slowed or stopped enrollment in some cancer clinical trials.
by Kate Yandell
-
Registries Report on COVID-19 and CancerData shed light on risk factors for death among people with cancer infected with the coronavirus.
by Kate Yandell
-
Forward Look
Managing Opioid-Related ConstipationPatients may be wary of discussing this common side effect.
by Sue Rochman
-
-
Can CRISPR Deliver?A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?
by Stephen Ornes
-
International Perspectives on COVID-19 and CancerResearchers from around the globe share insights into the outcomes of people with cancer who are infected with the coronavirus.
by Bradley Jones
-
The Puzzle of Pancreatic CancerPancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend.
by Kendall K. Morgan
-
Tests Spot Signs of Cancer in the BloodAt the AACR Virtual Annual Meeting I, researchers presented data on blood tests that aim to supplement current cancer screening and speed up diagnosis.
by Kate Yandell
-
Policy Matters
Taking Steps to Address Cancer Health DisparitiesCancer outcomes are changing for the better, but advances are not affecting all patients equally.
by Brian Rivers, PhD
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
